Regulation of interleukin-10 gene expression in macrophages engulfing apoptotic cells

Journal of Interferon and Cytokine Research

Volumn 30, Issue 3, 2010, Pages 113-121

  Zhang, Yan ^a   Kim, Ha Jeong ^a   Yamamoto, Soichiro ^a   Kang, Xiaoyan ^a   Ma, Xiaojing ^a,b  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b Weill Cornell Graduate School of Biomedical Sciences   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; TRANSFORMING GROWTH FACTOR BETA;

APOPTOSIS; AUTOIMMUNITY; CELL GROWTH; CELLULAR STRESS RESPONSE; CYTOKINE PRODUCTION; GENE CONTROL; GENE EXPRESSION REGULATION; HOMEOSTASIS; HUMAN; MACROPHAGE; NONHUMAN; PHAGOCYTE; PHAGOCYTOSIS; PRIORITY JOURNAL; REVIEW;

ANIMALS; APOPTOSIS; GENE EXPRESSION REGULATION; HUMANS; INFLAMMATION; INTERLEUKIN-10; MACROPHAGES; MODELS, BIOLOGICAL; SIGNAL TRANSDUCTION;

EID: 77949797615     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/jir.2010.0004     Document Type: Review

References (123)

1. Aguilar-Quesada R, Muñoz-Gámez JA, Martín-Oliva D, Peralta-Leal A, Quiles-Pérez R, Rodríguez-Vargas JM, Ruiz de Almodóvar M, Conde C, Ruiz-Extremera A, Oliver FJ. 2007. Modulation of transcription by PARP-1: consequences in carcinogenesis and infl ammation. Curr Med Chem 14(11):1179-1187.
2. Akiyama T, Takasawa S, Nata K, Kobayashi S, Abe M, Shervani NJ, Ikeda T, Nakagawa K, Unno M, Matsuno S, Okamoto H. 2001. Activation of Reg gene, a gene for insulin-producing beta-cell regeneration: poly(ADP-ribose) polymerase binds Reg promoter and regulates the transcription by autopoly(ADP-ribosyl)ation. Proc Natl Acad Sci USA 98(1):48-53.
3. Alizadeh AA, Eisen MB, Davis RE, Ma C, Lossos IS, Rosenwald A, Boldrick JC, Sabet H, Tran T, Yu X, Powell JI, Yang L, Marti GE, Moore T, Hudson J Jr, Lu L, Lewis DB, Tibshirani R, Sherlock G, Chan WC, Greiner TC, Weisenburger DD, Armitage JO, Warnke R, Levy R, Wilson W, Grever MR, Byrd JC, Botstein D, Brown PO, Staudt LM. 2000. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 403(6769):503-511.
4. Ambrose HE, Papadopoulou V, Beswick RW, Wagner SD. 2007. Poly-(ADP-ribose) polymerase-1 (Parp-1) binds in a sequence-specific manner at the Bcl-6 locus and contributes to the regulation of Bcl-6 transcription. Oncogene 26(42):6244-6252.
5. Armstrong L, Millar AB. 1997. Relative production of tumour necrosis factor alpha and interleukin 10 in adult respiratory distress syndrome. Thorax 52(5):442-446.
6. Balasubramanian K, Chandra J, Schroit AJ. 1997. Immune clearance of phosphatidylserine-expressing cells by phagocytes. The role of beta2-glycoprotein I in macrophage recognition. J Biol Chem 272(49):31113-31117.
7. Baumann I, Kolowos W, Voll RE, Manger B, Gaipl U, Neuhuber WL, Kirchner T, Kalden JR, Herrmann M. 2002. Impaired uptake of apoptotic cells into tingible body macrophages in germinal centers of patients with systemic lupus erythematosus. Arthritis Rheum 46(1):191-201.
8. Benkhart EM, Siedlar M, Wedel A, Werner T, Ziegler-Heitbrock HW. 2000. Role of Stat3 in lipopolysaccharide-induced IL-10 gene expression. J Immunol 165(3):1612-1617.
9. Bickerstaff MC, Botto M, Hutchinson WL, Herbert J, Tennent GA, Bybee A, Mitchell DA, Cook HT, Butler PJ, Walport MJ, Pepys MB. 1999. Serum amyloid P component controls chromatin degradation and prevents antinuclear autoimmunity. Nat Med 5(6):694-697.
10. Bienvenu J, Doche C, Gutowski MC, Lenoble M, Lepape A, Perdrix JP. 1995. Production of proinflammatory cytokines and cytokines involved in the TH1/TH2 balance is modulated by pentoxifylline. J Cardiovasc Pharmacol 25(Suppl. 2):S80-S84
11. Böhm I. 2006. [The apoptosis marker enzyme poly-(ADP-ribose) polymerase (PARP) in systemic lupus erythematosus]. Z Rheumatol 65(6):541-544.
12. Borisenko GG, Iverson SL, Ahlberg S, Kagan VE, Fadeel B. 2004. Milk fat globule epidermal growth factor 8 (MFG-E8) binds to oxidized phosphatidylserine: implications for macrophage clearance of apoptotic cells. Cell Death Differ 11(8):943-945.
13. Bratton DL, Fadok VA, Richter DA, Kailey JM, Guthrie LA, Henson PM. 1997. Appearance of phosphatidylserine on apoptotic cells requires calcium-mediated nonspecific fl ip-fl op and is enhanced by loss of the aminophospholipid translocase. J Biol Chem 272(42):26159-26165.
14. Brightbill HD, Plevy SE, Modlin RL, Smale ST. 2000. A prominent role for Sp1 during lipopolysaccharide-mediated induction of the IL-10 promoter in macrophages. J Immunol 164(4):1940-1951.
15. Cao S, Zhang X, Edwards JP, Mosser DM. 2006. NF-kappaB1 (p50) homodimers differentially regulate pro-and anti-inflammatory cytokines in macrophages. J Biol Chem 281(36):26041-26050.
16. Carson WE, Lindemann MJ, Baiocchi R, Linett M, Tan JC, Chou CC, Narula S, Caligiuri MA. 1995. The functional characterization of interleukin-10 receptor expression on human natural killer cells. Blood 85(12):3577-3585.
17. Chiarugi A. 2002. Inhibitors of poly(ADP-ribose) polymerase-1 suppress transcriptional activation in lymphocytes and ameliorate autoimmune encephalomyelitis in rats. Br J Pharmacol 137(6):761-770.
18. Chong WP, Ip WK, Wong WH, Lau CS, Chan TM, Lau YL. 2004. Association of interleukin-10 promoter polymorphisms with systemic lupus erythematosus. Genes Immun 5(6):484-492.
19. Chung EY, Liu J, Homma Y, Zhang Y, Brendolan A, Saggese M, Han J, Silverstein R, Selleri L, Ma X. 2007a. Interleukin-10 expression in macrophages during phagocytosis of apoptotic cells is mediated by homeodomain proteins Pbx1 and Prep-1. Immunity 27(6):952-964.
20. Chung EY, Liu J, Zhang Y, Ma X. 2007b. Differential expression in lupus-associated IL-10 promoter single-nucleotide polymorphisms is mediated by poly(ADP-ribose) polymerase-1. Genes Immun 8(7):577-589.
21. Cox G, Crossley J, Xing Z. 1995. Macrophage engulfment of apoptotic neutrophils contributes to the resolution of acute pulmonary infl ammation in vivo. Am J Respir Cell Mol Biol 12(2):232-237.
22. Crawley E, Kay R, Sillibourne J, Patel P, Hutchinson I, Woo P. 1999. Polymorphic haplotypes of the interleukin-10 5? fl anking region determine variable interleukin-10 transcription and are associated with particular phenotypes of juvenile rheumatoid arthritis. Arthritis Rheum 42(6):1101-1108.
23. D'Alfonso S, Rampi M, Rolando V, Giordano M, Momigliano-Richiardi P. 2000. New polymorphisms in the IL-10 promoter region. Genes Immun 1(3):231-233.
24. D'Amours D, Sallmann FR, Dixit VM, Poirier GG. 2001. Gain-offunction of poly(ADP-ribose) polymerase-1 upon cleavage by apoptotic proteases: implications for apoptosis. J Cell Sci 114(Pt 20):3771-3778.
25. Daleke DL, Lyles JV. 2000. Identification and purification of aminophospholipid fl ippases. Biochim Biophys Acta 1486(1):108-127.
26. de Murcia G, Ménissier-de Murcia J, Schreiber V. 1991. Poly(ADPribose) polymerase: molecular biological aspects. Bioessays 13(9):455-462.
27. de Waal Malefyt R, Abrams J, Bennett B, Figdor CG, de Vries JE. 1991. Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 174(5):1209-1220.
28. Derkx B, Marchant A, Goldman M, Bijlmer R, van Deventer S. 1995. High levels of interleukin-10 during the initial phase of fulminant meningococcal septic shock. J Infect Dis 171(1):229-232.
29. Donnelly SC, Strieter RM, Reid PT, Kunkel SL, Burdick MD, Armstrong I, Mackenzie A, Haslett C. 1996. The association between mortality rates and decreased concentrations of interleukin-10 and interleukin-1 receptor antagonist in the lung fluids of patients with the adult respiratory distress syndrome. Ann Intern Med 125(3):191-196.
30. Du Clos TW, Zlock LT, Hicks PS, Mold C. 1994. Decreased autoantibody levels and enhanced survival of (NZB x NZW) F1 mice treated with C-reactive protein. Clin Immunol Immunopathol 70(1):22-27.
31. Edwards-Smith CJ, Jonsson JR, Purdie DM, Bansal A, Shorthouse C, Powell EE. 1999. Interleukin-10 promoter polymorphism predicts initial response of chronic hepatitis C to interferon alfa. Hepatology 30(2):526-530.
32. Enghard P, Langnickel D, Riemekasten G. 2006. T cell cytokine imbalance towards production of IFN-gamma and IL-10 in NZB/W F1 lupus-prone mice is associated with autoantibody levels and nephritis. Scand J Rheumatol 35(3):209-216.
33. Eskdale J, Keijsers V, Huizinga T, Gallagher G. 1999. Microsatellite alleles and single nucleotide polymorphisms (SNP) combine to form four major haplotype families at the human interleukin-10 (IL-10) locus. Genes Immun 1(2):151-155.
34. Fadok VA, Voelker DR, Campbell PA, Cohen JJ, Bratton DL, Henson PM. 1992. Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J Immunol 148(7):2207-2216.
35. Friedman G, Jankowski S, Marchant A, Goldman M, Kahn RJ, Vincent JL. 1997. Blood interleukin 10 levels parallel the severity of septic shock. J Crit Care 12(4):183-187.
36. Fuss IJ, Boirivant M, Lacy B, Strober W. 2002. The interrelated roles of TGF-beta and IL-10 in the regulation of experimental colitis. J Immunol 168(2):900-908.
37. Gardai SJ, Bratton DL, Ogden CA, Henson PM. 2006. Recognition ligands on apoptotic cells: a perspective. J Leukoc Biol 79(5):896-903.
38. Gardai SJ, McPhillips KA, Frasch SC, Janssen WJ, Starefeldt A, Murphy-Ullrich JE, Bratton DL, Oldenborg PA, Michalak M, Henson PM. 2005. Cell-surface calreticulin initiates clearance of viable or apoptotic cells through trans-activation of LRP on the phagocyte. Cell 123(2):321-334.
39. Garin J, Diez R, Kieffer S, Dermine JF, Duclos S, Gagnon E, Sadoul R, Rondeau C, Desjardins M. 2001. The phagosome proteome: insight into phagosome functions. J Cell Biol 152(1):165-180.
40. Gibson AW, Edberg JC, Wu J, Westendorp RG, Huizinga TW, Kimberly RP. 2001. Novel single nucleotide polymorphisms in the distal IL-10 promoter affect IL-10 production and enhance the risk of systemic lupus erythematosus. J Immunol 166(6):3915-3922.
41. Gómez-Jiménez J, Martín MC, Sauri R, Segura RM, Esteban F, Ruiz JC, Nuvials X, Bóveda JL, Peracaula R, Salgado A. 1995. Interleukin-10 and the monocyte/macrophage-induced inflammatory response in septic shock. J Infect Dis 171(2):472-475.
42. Gong MN, Thompson BT, Williams PL, Zhou W, Wang MZ, Pothier L, Christiani DC. 2006. Interleukin-10 polymorphism in position-1082 and acute respiratory distress syndrome. Eur Respir J 27(4):674-681.
43. Grader-Beck T, Casciola-Rosen L, Lang TJ, Puliaev R, Rosen A, Via CS. 2007. Apoptotic splenocytes drive the autoimmune response to poly(ADP-ribose) polymerase 1 in a murine model of lupus. J Immunol 178(1):95-102.
44. Grigg JM, Savill JS, Sarraf C, Haslett C, Silverman M. 1991. Neutrophil apoptosis and clearance from neonatal lungs. Lancet 338(8769):720-722.
45. Gröndal G, Gunnarsson I, Rönnelid J, Rogberg S, Klareskog L, Lundberg I. 2000. Cytokine production, serum levels and disease activity in systemic lupus erythematosus. Clin Exp Rheumatol 18(5):565-570.
46. Hanayama R, Tanaka M, Miwa K, Shinohara A, Iwamatsu A, Nagata S. 2002. Identification of a factor that links apoptotic cells to phagocytes. Nature 417(6885):182-187.
47. Henson PM, Hume DA. 2006. Apoptotic cell removal in development and tissue homeostasis. Trends Immunol 27(5):244-250.
48. Herrmann M, Voll RE, Zoller OM, Hagenhofer M, Ponner BB, Kalden JR. 1998. Impaired phagocytosis of apoptotic cell material by monocyte-derived macrophages from patients with systemic lupus erythematosus. Arthritis Rheum 41(7):1241-1250.
49. Igonin AA, Armstrong VW, Shipkova M, Lazareva NB, Kukes VG, Oellerich M. 2004. Circulating cytokines as markers of systemic inflammatory response in severe community-acquired pneumonia. Clin Biochem 37(3):204-209.
50. Ishida H, Muchamuel T, Sakaguchi S, Andrade S, Menon S, Howard M. 1994. Continuous administration of anti-interleukin 10 antibodies delays onset of autoimmunity in NZB/W F1 mice. J Exp Med 179(1):305-310.
51. Ishimoto Y, Ohashi K, Mizuno K, Nakano T. 2000. Promotion of the uptake of PS liposomes and apoptotic cells by a product of growth arrest-specific gene, gas6. J Biochem 127(3):411-417.
52. Jaber BL, Rao M, Guo D, Balakrishnan VS, Perianayagam MC, Freeman RB, Pereira BJ. 2004. Cytokine gene promoter polymorphisms and mortality in acute renal failure. Cytokine 25(5):212-219.
53. Jeoung D, Lim Y, Lee EB, Lee S, Kim HY, Lee H, Song YW. 2004. Identification of autoantibody against poly (ADP-ribose) polymerase (PARP) fragment as a serological marker in systemic lupus erythematosus. J Autoimmun 22(1):87-94.
54. Jijon HB, Churchill T, Malfair D, Wessler A, Jewell LD, Parsons HG, Madsen KL. 2000. Inhibition of poly(ADP-ribose) polymerase attenuates infl ammation in a model of chronic colitis. Am J Physiol Gastrointest Liver Physiol 279(3):G641-G651.
55. Johanneson B, Lima G, von Salomé J, Alarcón-Segovia D, Alarcón-Riquelme ME; Collaborative Group on the Genetics of SLE, The BIOMED II Collaboration on the Genetics of SLE and Sjögrens syndrome. 2002. A major susceptibility locus for systemic lupus erythemathosus maps to chromosome 1q31. Am J Hum Genet 71(5):1060-1071.
56. Ju BG, Solum D, Song EJ, Lee KJ, Rose DW, Glass CK, Rosenfeld MG. 2004. Activating the PARP-1 sensor component of the groucho/ TLE1 corepressor complex mediates a CaMKinase IIdelta-dependent neurogenic gene activation pathway. Cell 119(6):815-829.
57. Kang X, Kim H, Ramirez M, Salameh S, Ma X. 2010. The septic shock-associated IL-10 1082 A>G polymorphism mediates allele-specific transcription via poly ADP-ribose polymerase 1 in macrophages engulfing apoptotic cells. J Immunol in press.
58. Khoa PD, Sugiyama T, Yokochi T. 2005. Polymorphism of interleukin-10 promoter and tumor necrosis factor receptor II in Vietnamese patients with systemic lupus erythematosus. Clin Rheumatol 24(1):11-13.
59. Kim S, Elkon KB, Ma X. 2004. Transcriptional suppression of interleukin-12 gene expression following phagocytosis of apoptotic cells. Immunity 21(5):643-653.
60. Kim SJ, Gershov D, Ma X, Brot N, Elkon KB. 2002. I-PLA(2) activation during apoptosis promotes the exposure of membrane lysophosphatidylcholine leading to binding by natural immunoglobulin M antibodies and complement activation. J Exp Med 196(5):655-665.
61. Kinchen JM, Ravichandran KS. 2008. Phagosome maturation: going through the acid test. Nat Rev Mol Cell Biol 9(10):781-795.
62. Kube D, Platzer C, von Knethen A, Straub H, Bohlen H, Hafner M, Tesch H. 1995. Isolation of the human interleukin 10 promoter. Characterization of the promoter activity in Burkitt's lymphoma cell lines. Cytokine 7(1):1-7.
63. Kühnle S, Nicotera P, Wendel A, Leist M. 1999. Prevention of endotoxin-induced lethality, but not of liver apoptosis in poly(ADPribose) polymerase-deficient mice. Biochem Biophys Res Commun 263(2):433-438.
64. Lazarus M, Hajeer AH, Turner D, Sinnott P, Worthington J, Ollier WE, Hutchinson IV. 1997. Genetic variation in the interleukin 10 gene promoter and systemic lupus erythematosus. J Rheumatol 24(12):2314-2317.
65. Lim Y, Lee DY, Lee S, Park SY, Kim J, Cho B, Lee H, Kim HY, Lee E, Song YW, Jeoung DI. 2002. Identification of autoantibodies associated with systemic lupus erythematosus. Biochem Biophys Res Commun 295(1):119-124.
66. Llorente L, Richaud-Patin Y, Couderc J, Alarcon-Segovia D, Ruiz-Soto R, Alcocer-Castillejos N, Alcocer-Varela J, Granados J, Bahena S, Galanaud P, Emilie D. 1997. Dysregulation of interleukin-10 production in relatives of patients with systemic lupus erythematosus. Arthritis Rheum 40(8):1429-1435.
67. Llorente L, Richaud-Patin Y, Wijdenes J, Alcocer-Varela J, Maillot MC, Durand-Gasselin I, Fourrier BM, Galanaud P, Emilie D. 1993. Spontaneous production of interleukin-10 by B lymphocytes and monocytes in systemic lupus erythematosus. Eur Cytokine Netw 4(6):421-427.
68. MacNeil IA, Suda T, Moore KW, Mosmann TR, Zlotnik A. 1990. IL-10, a novel growth cofactor for mature and immature T cells. J Immunol 145(12):4167-4173.
69. Marchant A, Devière J, Byl B, De Groote D, Vincent JL, Goldman M. 1994. Interleukin-10 production during septicaemia. Lancet 343(8899):707-708.
70. Martens HA, Nolte IM, van der Steege G, Schipper M, Kallenberg CG, te Meerman GJ, Bijl M. 2007. Association of poly(ADP-ribose) polymerase 1 and a novel candidate locus, LOC127086, with systemic lupus erythematosus. Ann Rheum Dis 66(3):424-425.
71. McCoubrey-Hoyer A, Okarma TB, Holman HR. 1984. Partial purification and characterization of plasma DNA and its relation to disease activity in systemic lupus erythematosus. Am J Med 77(1):23-34.
72. Miyanishi M, Tada K, Koike M, Uchiyama Y, Kitamura T, Nagata S. 2007. Identification of Tim4 as a phosphatidylserine receptor. Nature 450(7168):435-439.
73. Moens CB, Selleri L. 2006. Hox cofactors in vertebrate development. Dev Biol 291(2):193-206.
74. Monneret G, Finck ME, Venet F, Debard AL, Bohé J, Bienvenu J, Lepape A. 2004. The anti-inflammatory response dominates after septic shock: association of low monocyte HLA-DR expression and high interleukin-10 concentration. Immunol Lett 95(2):193-198.
75. Moore KW, de Waal Malefyt R, Coffman RL, O'Garra A. 2001. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 19:683-765.
76. Moore KW, Vieira P, Fiorentino DF, Trounstine ML, Khan TA, Mosmann TR. 1990. Homology of cytokine synthesis inhibitory factor (IL-10) to the Epstein-Barr virus gene BCRFI. Science 248(4960):1230-1234.
77. Morris RG, Hargreaves AD, Duvall E, Wyllie AH. 1984. Hormoneinduced cell death. 2. Surface changes in thymocytes undergoing apoptosis. Am J Pathol 115(3):426-436.
78. Nagata K, Ohashi K, Nakano T, Arita H, Zong C, Hanafusa H, Mizuno K. 1996. Identification of the product of growth arrestspecific gene 6 as a common ligand for Axl, Sky, and Mer receptor tyrosine kinases. J Biol Chem 271(47):30022-30027.
79. Napirei M, Karsunky H, Zevnik B, Stephan H, Mannherz HG, Möröy T. 2000. Features of systemic lupus erythematosus in Dnase1-deficient mice. Nat Genet 25(2):177-181.
80. Neidhardt R, Keel M, Steckholzer U, Safret A, Ungethuem U, Trentz O, Ertel W. 1997. Relationship of interleukin-10 plasma levels to severity of injury and clinical outcome in injured patients. J Trauma 42(5):863-870; discussion 870.
81. Oberholzer A, Oberholzer C, Moldawer LL. 2002. Interleukin-10: A complex role in the pathogenesis of sepsis syndromes and its potential as an anti-inflammatory drug. Crit Care Med 30(1 Suppl):S58-S63.
82. Oliver FJ, Ménissier-de Murcia J, Nacci C, Decker P, Andriantsitohaina R, Muller S, de la Rubia G, Stoclet JC, de Murcia G. 1999. Resistance to endotoxic shock as a consequence of defective NF-kappaB activation in poly (ADP-ribose) polymerase-1 deficient mice. EMBO J 18(16):4446-4454.
83. Païdassi H, Tacnet-Delorme P, Garlatti V, Darnault C, Ghebrehiwet B, Gaboriaud C, Arlaud GJ, Frachet P. 2008. C1q binds phosphatidylserine and likely acts as a multiligand-bridging molecule in apoptotic cell recognition. J Immunol 180(4):2329-2338.
84. Park D, Tosello-Trampont AC, Elliott MR, Lu M, Haney LB, Ma Z, Klibanov AL, Mandell JW, Ravichandran KS. 2007. BAI1 is an engulfment receptor for apoptotic cells upstream of the ELMO/ Dock180/Rac module. Nature 450(7168):430-434.
85. Park SY, Jung MY, Kim HJ, Lee SJ, Kim SY, Lee BH, Kwon TH, Park RW, Kim IS. 2008. Rapid cell corpse clearance by stabilin-2, a membrane phosphatidylserine receptor. Cell Death Differ 15(1):192-201.
86. Parsons PE, Moss M, Vannice JL, Moore EE, Moore FA, Repine JE. 1997. Circulating IL-1ra and IL-10 levels are increased but do not predict the development of acute respiratory distress syndrome in at-risk patients. Am J Respir Crit Care Med 155(4):1469-1473.
87. Pavri R, Lewis B, Kim TK, Dilworth FJ, Erdjument-Bromage H, Tempst P, de Murcia G, Evans R, Chambon P, Reinberg D. 2005. PARP-1 determines specificity in a retinoid signaling pathway via direct modulation of mediator. Mol Cell 18(1):83-96.
88. Perniok A, Wedekind F, Herrmann M, Specker C, Schneider M. 1998. High levels of circulating early apoptic peripheral blood mononuclear cells in systemic lupus erythematosus. Lupus 7(2):113-118.
89. Pétrilli V, Herceg Z, Hassa PO, Patel NS, Di Paola R, Cortes U, Dugo L, Filipe HM, Thiemermann C, Hottiger MO, Cuzzocrea S, Wang ZQ. 2004. Noncleavable poly(ADP-ribose) polymerase-1 regulates the infl ammation response in mice. J Clin Invest 114(8):1072-1081.
90. Ramprasad MP, Fischer W, Witztum JL, Sambrano GR, Quehenberger O, Steinberg D. 1995. The 94-to 97-kDa mouse macrophage membrane protein that recognizes oxidized low density lipoprotein and phosphatidylserine-rich liposomes is identical to macrosialin, the mouse homologue of human CD68. Proc Natl Acad Sci USA 92(21):9580-9584.
91. Raptis L, Menard HA. 1980. Quantitation and characterization of plasma DNA in normals and patients with systemic lupus erythematosus. J Clin Invest 66(6):1391-1399.
92. Robinson SC, Scott KA, Wilson JL, Thompson RG, Proudfoot AE, Balkwill FR. 2003. A chemokine receptor antagonist inhibits experimental breast tumor growth. Cancer Res 63(23):8360-8365.
93. Rodríguez-Gaspar M, Santolaria F, Jarque-López A, González-Reimers E, Milena A, de la Vega MJ, Rodríguez- Rodríguez E, Gómez-Sirvent JL. 2001. Prognostic value of cytokines in SIRS general medical patients. Cytokine 15(4):232-236.
94. Roy S, Knox K, Segal S, Griffiths D, Moore CE, Welsh KI, Smarason A, Day NP, McPheat WL, Crook DW, Hill AV; Oxford Pneumoccocal Surveillance Group. 2002. MBL genotype and risk of invasive pneumococcal disease: a case-control study. Lancet 359(9317):1569-1573.
95. Savill J, Fadok V, Henson P, Haslett C. 1993. Phagocyte recognition of cells undergoing apoptosis. Immunol Today 14(3):131-136.
96. Schaaf BM, Boehmke F, Esnaashari H, Seitzer U, Kothe H, Maass M, Zabel P, Dalhoff K. 2003. Pneumococcal septic shock is associated with the interleukin-10-1082 gene promoter polymorphism. Am J Respir Crit Care Med 168(4):476-480.
97. Schall TJ, Bacon K, Toy KJ, Goeddel DV. 1990. Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES. Nature 347(6294):669-671.
98. Scott RS, McMahon EJ, Pop SM, Reap EA, Caricchio R, Cohen PL, Earp HS, Matsushima GK. 2001. Phagocytosis and clearance of apoptotic cells is mediated by MER. Nature 411(6834):207-211.
99. Simmons EM, Himmelfarb J, Sezer MT, Chertow GM, Mehta RL, Paganini EP, Soroko S, Freedman S, Becker K, Spratt D, Shyr Y, Ikizler TA; PICARD Study Group. 2004. Plasma cytokine levels predict mortality in patients with acute renal failure. Kidney Int 65(4):1357-1365.
100. Somersan S, Bhardwaj N. 2001. Tethering and tickling: a new role for the phosphatidylserine receptor. J Cell Biol 155(4):501-504.
101. Song E, Zhu P, Lee SK, Chowdhury D, Kussman S, Dykxhoorn DM, Feng Y, Palliser D, Weiner DB, Shankar P, Marasco WA, Lieberman J. 2005. Antibody mediated in vivo delivery of small interfering RNAs via cell-surface receptors. Nat Biotechnol 23(6):709-717.
102. Stanilova SA, Miteva LD, Karakolev ZT, Stefanov CS. 2006. Interleukin-10-1082 promoter polymorphism in association with cytokine production and sepsis susceptibility. Intensive Care Med 32(2):260-266.
103. Steinhauser ML, Hogaboam CM, Kunkel SL, Lukacs NW, Strieter RM, Standiford TJ. 1999. IL-10 is a major mediator of sepsis-induced impairment in lung antibacterial host defense. J Immunol 162(1):392-399.
104. Steinman CR. 1984. Circulating DNA in systemic lupus erythematosus. Isolation and characterization. J Clin Invest 73(3):832-841.
105. Stuart LM, Boulais J, Charriere GM, Hennessy EJ, Brunet S, Jutras I, Goyette G, Rondeau C, Letarte S, Huang H, Ye P, Morales F, Kocks C, Bader JS, Desjardins M, Ezekowitz RA. 2007. A systems biology analysis of the Drosophila phagosome. Nature 445(7123):95-101.
106. Sun EW, Shi YF. 2001. Apoptosis: the quiet death silences the immune system. Pharmacol Ther 92(2-3):135-145.
107. Szabó C, Dawson VL. 1998. Role of poly(ADP-ribose) synthetase in infl ammation and ischaemia-reperfusion. Trends Pharmacol Sci 19(7):287-298.
108. Teague TK, Hildeman D, Kedl RM, Mitchell T, Rees W, Schaefer BC, Bender J, Kappler J, Marrack P. 1999. Activation changes the spectrum but not the diversity of genes expressed by T cells. Proc Natl Acad Sci USA 96(22):12691-12696.
109. Tsao BP. 2000. Lupus susceptibility genes on human chromosome 1. Int Rev Immunol 19(4-5):319-334.
110. Tsao BP, Cantor RM, Kalunian KC, Chen CJ, Badsha H, Singh R, Wallace DJ, Kitridou RC, Chen SL, Shen N, Song YW, Isenberg DA, Yu CL, Hahn BH, Rotter JI. 1997. Evidence for linkage of a candidate chromosome 1 region to human systemic lupus erythematosus. J Clin Invest 99(4):725-731.
111. Tulin A, Stewart D, Spradling AC. 2002. The Drosophila heterochromatic gene encoding poly(ADP-ribose) polymerase (PARP) is required to modulate chromatin structure during development. Genes Dev 16(16):2108-2119.
112. Turner DM, Williams DM, Sankaran D, Lazarus M, Sinnott PJ, Hutchinson IV. 1997. An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet 24(1):1-8.
113. van der Poll T, Marchant A, Keogh CV, Goldman M, Lowry SF. 1996. Interleukin-10 impairs host defense in murine pneumococcal pneumonia. J Infect Dis 174(5):994-1000.
114. Vance JE, Steenbergen R. 2005. Metabolism and functions of phosphatidylserine. Prog Lipid Res 44(4):207-234.
115. Vaux DL, Korsmeyer SJ. 1999. Cell death in development. Cell 96(2):245-254.
116. Virág L, Bai P, Bak I, Pacher P, Mabley JG, Liaudet L, Bakondi E, Gergely P, Kollai M, Szabó C. 2004. Effects of poly(ADP-ribose) polymerase inhibition on inflammatory cell migration in a murine model of asthma. Med Sci Monit 10(3):BR77-BR83.
117. Voll RE, Roth EA, Girkontaite I, Fehr H, Herrmann M, Lorenz HM, Kalden JR. 1997. Histone-specific Th0 and Th1 clones derived from systemic lupus erythematosus patients induce double-stranded DNA antibody production. Arthritis Rheum 40(12):2162-2171.
118. Westendorp RG, Langermans JA, Huizinga TW, Elouali AH, Verweij CL, Boomsma DI, Vandenbroucke JP, Vandenbrouke JP. 1997. Genetic infl uence on cytokine production and fatal meningococcal disease. Lancet 349(9046):170-173.
119. Williamson P, Schlegel RA. 2002. Transbilayer phospholipid movement and the clearance of apoptotic cells. Biochim Biophys Acta 1585(2-3):53-63.
120. Yilmaz V, Yentür SP, Saruhan-Direskeneli G. 2005. IL-12 and IL-10 polymorphisms and their effects on cytokine production. Cytokine 30(4):188-194.
121. Yung TM, Satoh MS. 2001. Functional competition between poly(ADPribose) polymerase and its 24-kDa apoptotic fragment in DNA repair and transcription. J Biol Chem 276(14):11279-11286.
122. Zhang DL, Zheng HM, Yu BJ, Jiang ZW, Li JS. 2005. Association of polymorphisms of IL and CD14 genes with acute severe pancreatitis and septic shock. World J Gastroenterol 11(28):4409-4413.
123. Zimmermann TS, Lee AC, Akinc A, Bramlage B, Bumcrot D, Fedoruk MN, Harborth J, Heyes JA, Jeffs LB, John M, Judge AD, Lam K, McClintock K, Nechev LV, Palmer LR, Racie T, Röhl I, Seiffert S, Shanmugam S, Sood V, Soutschek J, Toudjarska I, Wheat AJ, Yaworski E, Zedalis W, Koteliansky V, Manoharan M, Vornlocher HP, MacLachlan I. 2006. RNAi-mediated gene silencing in non-human primates. Nature 441(7089):111-114.